In CRC patients, the binding of VEGF/VEGFR results in migration, invasion, and survival of cancer cells, while the binding of EGF/EGFR results in cell proliferation, vascular permeability, and cancer cell survival, all leading to angiogenesis which is one of the main derivers of CRC [3]. The gene discussed is EGF; the disease is colorectal carcinoma.